氯吡格雷

  • 网络clopidogrel;plavix
氯吡格雷氯吡格雷
  1. 氯吡格雷对支气管哮喘小鼠血小板源性P选择素及肺泡中性粒细胞的影响

    The Effects of Clopidogrel on P-selectin Derived from Platelets and Neutrophil from BAL of Asthmatic Mice Model

  2. 辛伐他汀并氯吡格雷对急性冠脉综合症患者高敏C反应蛋白及血脂的影响

    Effects of simvastatin combined with clopidogrel on hs-CRP and blood lipids in patients with acute coronary syndrome

  3. 阿司匹林和溶栓疗法加用氯吡格雷治疗ST段抬高心肌梗死

    Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

  4. 尿激酶联合氯吡格雷阿司匹林治疗急性ST段抬高型心肌梗塞疗效

    Efficiency of urokinase combined clopidogrel and aspirin in the patients with ST-segment elevation myocardial infarction

  5. ST段抬高急性心肌梗死纤溶治疗加用氯吡格雷的临床研究

    The study on addition of clopidogrel to fibrinolytic therapy for myocardial infarction with ST-segment elevation

  6. 氯吡格雷联合阿司匹林、溶栓治疗急性ST段抬高型心肌梗死的疗效观察

    Addition of clopidogrel to aspirin and fibrinolytic therapy for acute myocardial infarction with ST-segment elevation

  7. 氯吡格雷对急性ST段抬高心肌梗死溶栓的疗效和安全性

    Efficacy and safety of fibrinolytic therapy plus clopidogrel for patients with acute ST-segment elevation myocardial infarction

  8. 因此,增加氯吡格雷的给药剂量可被视为防治CR的可靠方法。

    Therefore , the increase in clopidogrel dose can be regarded as a reliable method for prevention of CR.

  9. 但国内缺乏针对国产与进口氯吡格雷在PCI中应用的系统研究。

    But there is no systematic study on domestic and imported clopidogrel used in PCI .

  10. 进口和国产氯吡格雷对PCI术后的血小板功能及预后的影响

    Effects of domestic clopidogrel and imported clopidogrel on platelet function and its prognosis after PCI

  11. 氯吡格雷对非ST抬高急性冠脉综合征病人炎症因子及其预后的影响

    Effects of clopidogrel on hs-CRP and TNF - α in non-ST-segment elevation acute coronary artery syndromes patients

  12. 拟行冠状动脉搭桥术的非ST段抬高型急性冠状动脉综合征患者中急性使用氯吡格雷与预后的关系

    Acute Clopidogrel Use and Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

  13. 氯吡格雷在非ST段抬高心肌梗死患者急诊冠脉介入治疗中的作用

    Value of clopidogrel in emergency corona interventional therapy for myocardial infarction patients with non-ST segment elevation : report of 112 cases

  14. 结论冠心病患者PCI术后缺血事件的发生,可能与对氯吡格雷的抵抗有关。

    Conclusion There may be some relationship between the ischemic events of PCI patients and their drug resistance to clopidogrel .

  15. 目的观察常规溶栓联合氯吡格雷治疗对急性ST段抬高型心肌梗死近期心脏事件的影响。

    Objective To observe the effect on addition of clopidogrel to aspirin and fibrinolytic therapy for acute myocardial infarction with ST-segment elevation .

  16. 目的观察氯吡格雷对缺血性脑血管病患者阿司匹林抵抗(AR)的影响。

    Objective To explore the effect of clopidogrel bisulfate on aspirin resistance ( AR ) in patients with ischemic cerebrovascular disease .

  17. 预服氯吡格雷对冠状动脉支架术后患者PAI-1和t-PA的影响

    Changes of PAI-1 and t-PA after coronary stent implantation with Clopidogrel pretreatment

  18. 氯吡格雷在ST段抬高型心肌梗死溶栓后早期和持续动脉开放中的作用:ECGCLARITY-TIMI28研究

    The Role of Clopidogrel in Early and Sustained Arterial Patency After Fibrinolysis for ST-Segment Elevation Myocardial Infarction . The ECG CLARITY-TIMI 28 Study

  19. 由增加氯吡格雷给药剂量所带来的临床收益即便在存在CR的人群中亦可在一定程度上实现。

    The clinical benefits brought about by the increase in the clopidogrel dose or to a certain extent even in the existence of the CR crowd .

  20. 阿司匹林过敏的患者,推荐氯吡格雷(1A级)。

    For patients who are allergic to aspirin , we recommend clopidogrel ( Grade1A ) .

  21. 结论:氯吡格雷具有一定的抗AS作用,机制可能与抑制hs-CRP及NF-κB表达有关。

    Conclusion Clopidogel plays a role in protection against atherosclerosis , which may be associated with inhibiting the expressions of hs-CRP and NF - κ B.

  22. 去年,FDA就增加了一项关于一种抗凝血药物:clopidogre(氯吡格雷)的警告。

    For example , last year the FDA added a warning to the prescribing info for the widely used clopidogrel .

  23. 最新的指南强烈推荐双重抗血小板治疗氯吡格雷与阿司匹林连用于ACS和要行PCI术的患者。

    Current guidelines recommend dual anti-platelet therapy with a combination of aspirin and clopidogrel for patients who have ACS or undergo PCI .

  24. 水蛭素合用阿司匹林与氯吡格雷治疗TIA的疗效和卫生经济学比较

    Comparison between hirudin with aspirin and clopidogrel for the treatment of TIA in therapeutic effect and hygienic economics

  25. 氯吡格雷对GES-1细胞的损伤呈浓度依赖性(P0.05),无时间依赖性。

    GES-1 cells injury was induced by clopidogrel in a concentration-dependent manner , but in no obvious time-dependent manner .

  26. 方法:102例ACS患者被随机分成两组:普伐他汀组(P组)和阿托伐他汀组(A组),两组均予氯吡格雷300mg顿服后,75mg/d维持。

    Methods : A total of 102 ACS cases were randomly divided into two groups : pravastatin group ( 50 cases , treated with pravastatin );

  27. 所有入选患者术前常规采集病史及常规化验检查,PCI围手术期均给予阿司匹林、氯吡格雷、低分子肝素等冠心病标准化治疗。

    All selected patients were conventionally collected history and underwent laboratory examination , given aspirin , clopidogrel , low molecular heparin and so on in PCI perioperative period .

  28. 氯吡格雷对稳定性冠心病患者可溶性CD40配体和高敏C-反应蛋白的影响

    Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease

  29. 氯吡格雷是一种新型噻吩吡啶类衍生物,能阻断由ADP诱导的血小板聚集。

    Clopidogrel , a new type of thienopyridine derivative , inhibits platelet aggregation induced by adenosine diphosphate ( ADP ) .

  30. 随着氯吡格雷药物浓度增加,GES-1细胞的凋亡率亦随之增加。

    The apoptosis rate of GES-1 cells was increased with drug concentration .